MPO and pancreatitis: Administration of high doses of L-arginine, which is used as a relatively easy and reproducible model of pancreatitis, leads to significantly increased plasma amylase, pancreatic MPO activity, trypsin activation, and histological changes resembling acute pancreatitis in humans [27], [28].